Buscar resultados de ensayos clínicos
Langerhans Cell Histiocytosis - 3 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Mirdametinib in Histiocytic Disorders Condición: Langerhans Cell Histiocytosis (LCH) Fecha: 2025-07-31 Intervenciones: Mirdametinib is administered at a dose of 2 mg/m2, twice a day (BID) with a maximum dose of 4 mg BID on a continuous daily schedule.Consecu |
| Completed |
Nombre del estudio: LCH in Adults: a Collaborative, Prospective-retrospective, Observational Study Condición: Langerhans Cell Histiocytosis Fecha: 2025-07-31 Intervenciones: Diagnostic and therapeutic data of adult patients with LCH, collected from clinical and laboratory evaluations, carried out during clinical practice. |
| COMPLETED |
Nombre del estudio: Denosumab for the Treatment of Adult LCH Condición: Langerhans Cell Histiocytosis Fecha: 2025-07-31 Intervenciones: As already described in arm description |